Stock PTPI PETROS PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Petros Pharmaceuticals

Equities

PTPI

US71678J2096

Market Closed - Nasdaq
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
0.645 USD -5.84% Intraday chart for Petros Pharmaceuticals -1.83% -54.26%
04-23 Petros, Lemonaid Health Collaborate to Expand Stendra Availability MT
04-23 Petros Pharmaceuticals, Inc. Expands Online Distribution for Prescription STENDRA Through New Agreement with Lemonaid Health CI

Evolution of the average Target Price on Petros Pharmaceuticals

Price target over the last 5 years

History of analyst recommendation changes

e825bbbcdab9b49c5.0AFL_PIJ_dNlGl4lQV4MwKSz7CRs9lDuD_Y8ZvDeoRQ.gTUxqIJEy78hUT1SOSpi8JzE1EsVhzmDTrhXEYeU5X7pWBKbuVG6vxZ_Dw~28e58541198e99aafac75cbc4e64f54b

Analyst Recommendations on Petros Pharmaceuticals

Maxim Initiates Petros Pharma at Buy Rating With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.645 USD
Average target price
4 USD
Spread / Average Target
+520.16%
High Price Target
4 USD
Spread / Highest target
+520.16%
Low Price Target
4 USD
Spread / Lowest Target
+520.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Petros Pharmaceuticals

Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PTPI Stock
  4. Consensus Petros Pharmaceuticals